Can-Fite Biopharma (CANF) Q2 2025 Earnings

22MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0
-0
-0
-0

Details

Expected EPS
-0.000333
Actual EPS
-0.000333
Surprise EPS
0
Surprise Percent
+0%

Description

Can-Fite Biopharma (CANF) has reported earnings of -0.000333 per share for Q2 2025.

0 Comments

Share your thoughts